The Niche

Patents on making iPS cells, and deriving cardiomyocytes from human ES cells

In a couple unrelated patent filings, Kyoto University has announced a patent for reprogramming differentiated cells to an embryonic stem-cell like state, and Geron announced that it has a patent on using cardiomyocytes created from human embryonic stem cells as medicines or drug-screening technology. 

BACK TO ARTICLE

Tell a Friend

Please ensure that your friend is content to receive an email from us with a link to the article. Select the following link to view our Privacy Policy.

BACK TO ARTICLE